pubmed-article:11868893 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11868893 | lifeskim:mentions | umls-concept:C0085494 | lld:lifeskim |
pubmed-article:11868893 | lifeskim:mentions | umls-concept:C0521362 | lld:lifeskim |
pubmed-article:11868893 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:11868893 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
pubmed-article:11868893 | lifeskim:mentions | umls-concept:C1136254 | lld:lifeskim |
pubmed-article:11868893 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:11868893 | pubmed:dateCreated | 2002-2-28 | lld:pubmed |
pubmed-article:11868893 | pubmed:abstractText | Eradication of gastrointestinal colonization with vancomycin-resistant enterococci (VRE) using a combination of oral bacitracin and gentamicin was evaluated. Twenty-eight evaluable treated patients were matched with 28 control patients. After 3 months of follow-up, 5 patients (18%) in the treatment group versus 1 patient (4%) in the control group (P = .2) had negative results on stool cultures, with a similar frequency of VRE bacteremia (P = .8). The use of oral bacitracin plus gentamicin did not reduce VRE colonization or bacteremia. | lld:pubmed |
pubmed-article:11868893 | pubmed:language | eng | lld:pubmed |
pubmed-article:11868893 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11868893 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11868893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11868893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11868893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11868893 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11868893 | pubmed:month | Jan | lld:pubmed |
pubmed-article:11868893 | pubmed:issn | 0899-823X | lld:pubmed |
pubmed-article:11868893 | pubmed:author | pubmed-author:RaadIssamI | lld:pubmed |
pubmed-article:11868893 | pubmed:author | pubmed-author:HachemRayR | lld:pubmed |
pubmed-article:11868893 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11868893 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:11868893 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11868893 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11868893 | pubmed:pagination | 43-4 | lld:pubmed |
pubmed-article:11868893 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:meshHeading | pubmed-meshheading:11868893... | lld:pubmed |
pubmed-article:11868893 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:11868893 | pubmed:articleTitle | Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. | lld:pubmed |
pubmed-article:11868893 | pubmed:affiliation | Department of Internal Medicine Specialties, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. | lld:pubmed |
pubmed-article:11868893 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11868893 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11868893 | lld:pubmed |